Paracetamol Oral Solution 325mg/10ml

paracetamol-solution
  • Active Ingredient:Paracetamol
  • Content Specification:325mg Paracetamol per 10ml single specification
  • Pharmaceutical Form:Oral Solution
  • Applicable Standard:International pharmacopoeia specification, hospital clinical grade
  • Storage Condition:Sealed storage, protected from light and high temperature, kept in a cool and dry environment
  • Product Features:Precise low-dose formula, stable antipyretic and analgesic efficacy, mild and non-irritating, easy to take, high safety, suitable for clinical routine use and large-scale bulk procurement

Click to add this item to cart.

Product Description

  • Product Name:Paracetamol Oral Solution
  • Specification:325mg/10ml
  • Therapeutic Category:Analgesic & Antipyretic Agents / Oral Symptomatic Treatment Drugs
  • Core Product Positioning:Standard low-dose oral antipyretic and analgesic solution for precise symptomatic relief
  • Indicated For:Relief of fever caused by common cold and bacterial or viral infections; relief of mild to moderate pain such as headache, toothache, myalgia and joint pain
  • Usage Scenario:General outpatient departments, pediatric clinical care, community medical centers and daily family health care
  • Applicable Clients:Global medical institutions, pharmacy retail chains, pharmaceutical wholesalers and public health procurement organizations

Product Overview

Paracetamol Oral Solution 325mg/10ml is a classic mainstream antipyretic and analgesic oral preparation widely used in global clinical practice. It delivers stable fever-reducing and pain-relieving effects with mild gastrointestinal irritation and high safety, suitable for symptomatic treatment of fever and various mild pains in both adults and children.

Paracetamol Oral Solution 325mg/10ml: What the Published Guidance Says

The three non-opioid analgesics named on the WHO Model List — paracetamol, ibuprofen and acetylsalicylic acid — in the full range of oral, rectal and injectable presentations, plus the wider NSAID family.

Paracetamol Oral Solution 325mg/10ml sits in the Analgesics & NSAIDs range. The notes below are the ones that most often change a specification, a label or a tender submission.

These points are quoted because they shape how Paracetamol Oral Solution 325mg/10ml is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

Paracetamol Oral Solution 325mg/10ml: Specification, Pack & Documentation Summary

Therapeutic groupAnalgesics & NSAIDs — Analgesics & NSAIDs
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Acetaminophen Oral Solution 1000mg/30ml, Paracetamol Syrup 500mg per 15ml 100ml Bottle, Ibuprofen Suppository 50mg, Indomethacin Suppository 100mg, Naproxen Suppositories 250mg, Paracetamol Suppository 150mg, Diclofenac Sodium 50mg, Mefenamic 250mg Capsules.

How Paracetamol Oral Solution 325mg/10ml Is Tested and Released

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Paracetamol Oral Solution 325mg/10ml is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

Release testing on this presentation is built around:

  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing
  • Testing for description and identification
  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

How Paracetamol Oral Solution 325mg/10ml Is Packed, Labelled and Shipped

  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Regulatory Support for Paracetamol Oral Solution 325mg/10ml

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
  • Batch manufacturing and packaging records released for inspection on request during supplier audits.

This page describes Paracetamol Oral Solution 325mg/10ml as a product of the non-opioid analgesics and NSAIDs named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

Questions We Are Asked About Paracetamol Oral Solution 325mg/10ml

How is Paracetamol Oral Solution 325mg/10ml packaged?

Syrup presentations are quoted to your pack specification, with the artwork, pack size and labelling language confirmed before manufacture.

What documentation comes with a shipment of Paracetamol Oral Solution 325mg/10ml?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.

Does the batch documentation for Paracetamol Oral Solution 325mg/10ml support a registration filing?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Is diclofenac on the WHO Essential Medicines List?

No. The non-opioid analgesics named in section 2.1 are acetylsalicylic acid, ibuprofen and paracetamol. We supply diclofenac sodium in injectable and capsule form for markets whose national lists include it.

Can you supply sustained-release or combination analgesics?

Yes — including compound presentations and sustained-release forms. Confirm the specific combination against your national registration before ordering.

Companion Products — Analgesics & NSAIDs

Browse the full Analgesics & NSAIDs range; all Syrups; the complete product catalogue.

Request a Quotation for Paracetamol Oral Solution 325mg/10ml

Send the specification, pack size, quantity and destination market for Paracetamol Oral Solution 325mg/10ml 325mg/10ml and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products